# Effect of Brivaracetam in Photosensitive Epileptic Subjects

> **NCT00401648** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 20 (—)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT00401648
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 20 (—)
- **Last updated:** 2009-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401648, "Effect of Brivaracetam in Photosensitive Epileptic Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00401648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*